Matches in Nanopublications for { ?s ?p "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP849284.RAVau6Ry6VIBf9okDiD9_Z5Q8Yzl0xB1OYtBOiP2X47TA130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849284.RAVau6Ry6VIBf9okDiD9_Z5Q8Yzl0xB1OYtBOiP2X47TA130_provenance.
- NP937224.RAUiCF8CwLwe-uqW5gSpeMgDYBc-x8vUL73XAsbPE5-j4130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937224.RAUiCF8CwLwe-uqW5gSpeMgDYBc-x8vUL73XAsbPE5-j4130_provenance.
- NP384207.RAmDJD9Ted64VIZdhQiEyKR9mdKUlx-EmY0W4mvR707IA130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384207.RAmDJD9Ted64VIZdhQiEyKR9mdKUlx-EmY0W4mvR707IA130_provenance.
- NP388652.RAaaaQqajubjIIevH_VtN-lmvwkcHWNCXBTVErwj88mZw130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388652.RAaaaQqajubjIIevH_VtN-lmvwkcHWNCXBTVErwj88mZw130_provenance.
- NP874314.RApHSwmMP2gVwnk4WlA8W022oUL6Tlfss584vA79Z7jTI130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874314.RApHSwmMP2gVwnk4WlA8W022oUL6Tlfss584vA79Z7jTI130_provenance.
- NP756682.RAZkfxSCZmnjaD2dn7hIbe4-ZK1yNHp-7VjESKoiRMrmk130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756682.RAZkfxSCZmnjaD2dn7hIbe4-ZK1yNHp-7VjESKoiRMrmk130_provenance.
- NP866664.RAXTXriyhqQei7rABuWh3zC3SKkHjt1NH57_h5nf9WGoU130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866664.RAXTXriyhqQei7rABuWh3zC3SKkHjt1NH57_h5nf9WGoU130_provenance.
- assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP570113.RAUQP6R-HaGaCOTW71xgNeSXHTcF6Hih0qr74vLz9EHi8130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570113.RAUQP6R-HaGaCOTW71xgNeSXHTcF6Hih0qr74vLz9EHi8130_provenance.
- NP331568.RA_0wFvMJzXKEEHIYDlHwM3FHDykB9-XtcIWo9ueckwTM130_assertion description "[Marrow cells from 36 patients with myelodysplastic syndromes (MDS) (13 refractory anemia [RA], 14 refractory anemia with excess of blasts [RAEB], 9 RAEB in transformation [RAEB-T]) were evaluated for their in vitro proliferative and differentiative responsiveness to recombinant human granulocyte colony-stimulating factor (G-CSF) or granulocyte-monocyte CSF (GM-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331568.RA_0wFvMJzXKEEHIYDlHwM3FHDykB9-XtcIWo9ueckwTM130_provenance.